Stories
Slash Boxes
Comments

SoylentNews is people

SoylentNews is powered by your submissions, so send in your scoop. Only 17 submissions in the queue.
posted by martyb on Tuesday August 23 2016, @07:34AM   Printer-friendly
from the staying-alive-is-getting-more-expensive dept.

EpiPen's price has ballooned about 400% since 2008, rising from about a $100 list price to $500 today. The EpiPen is one of the most important life-saving medical innovations for people with severe food allergies—which affect as many as 15 million Americans and 1 in 13 children in the United States. But its price has exploded over the last decade despite few upgrades to the product itself. The product's lack of competitors is likely a significant driver of the costs. [...] [The] EpiPen enjoys a near-monopoly on the market with annual sales of more than $1.3 billion and nearly 90% U.S. market share.

At Fortune, NYT, The Hill.


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2) by isostatic on Tuesday August 23 2016, @08:56AM

    by isostatic (365) on Tuesday August 23 2016, @08:56AM (#392045) Journal

    Americans balk at it. The rest of as simply relieved.

    Starting Score:    1  point
    Karma-Bonus Modifier   +1  

    Total Score:   2